Issue 9, 2008

Enzymatic resolution and evaluation of enantiomers of cis-5′-hydroxythalidomide

Abstract

The straightforward synthesis of both enantiomers of cis-5′-hydroxythalidomide, a major metabolite of thalidomide, has been accomplished by enzymatic kinetic resolution of a racemic substrate catalyzed by Pseudomonas stutzeri lipase TL. cis-5′-Hydroxythalidomide shows resistance to racemization (and epimerization) at physiological pH. A tube formation assay to assess the ability to inhibit angiogenesis revealed that cis-5′-hydroxythalidomides are inactive.

Graphical abstract: Enzymatic resolution and evaluation of enantiomers of cis-5′-hydroxythalidomide

Supplementary files

Article information

Article type
Communication
Submitted
13 Feb 2008
Accepted
18 Mar 2008
First published
28 Mar 2008

Org. Biomol. Chem., 2008,6, 1540-1543

Enzymatic resolution and evaluation of enantiomers of cis-5′-hydroxythalidomide

T. Yamamoto, N. Shibata, M. Takashima, S. Nakamura, T. Toru, N. Matsunaga and H. Hara, Org. Biomol. Chem., 2008, 6, 1540 DOI: 10.1039/B802459F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements